Literature DB >> 11294832

Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1.

E A Walker1, A M Clark, M Hewison, J P Ride, P M Stewart.   

Abstract

11-beta-hydroxysteroid dehydrogenase type 1 catalyzes the conversion of cortisone to hormonally active cortisol and has been implicated in the pathogenesis of a number of disorders including insulin resistance and obesity. The enzyme is a glycosylated membrane-bound protein that has proved difficult to purify in an active state. Extracted enzyme typically loses the reductase properties seen in intact cells and shows principally dehydrogenase activity. The C-terminal catalytic domain is known to contain a disulfide bond and is located within the lumen of the endoplasmic reticulum, anchored to the membrane by a single N-terminal transmembrane domain. We report here the functional expression of the catalytic domain of the human enzyme, without the transmembrane domain and the extreme N terminus, in Escherichia coli. Moderate levels of soluble active protein were obtained using an N-terminal fusion with thioredoxin and a 6xHis tag. In contrast, the inclusion of a 6xHis tag at the C terminus adversely affected protein solubility and activity. However, the highest levels of active protein were obtained using a construct expressing the untagged catalytic domain. Nonreducing electrophoresis revealed the presence of both monomeric and dimeric disulfide bonded forms; however, mutation of a nonconserved cysteine residue resulted in a recombinant protein with no intermolecular disulfide bonds but full enzymatic activity. Using the optimal combination of plasmid construct and E. coli host strain, the recombinant protein was purified to apparent homogeneity by single step affinity chromatography. The purified protein possessed both dehydrogenase and reductase activities with a K(m) of 1.4 micrometer for cortisol and 9.5 micrometer for cortisone. This study indicates that glycosylation, the N-terminal region including the transmembrane helix, and intermolecular disulfide bonds are not essential for enzyme activity and that expression in bacteria can provide active recombinant protein for future structural and functional studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294832     DOI: 10.1074/jbc.M011142200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Mutations of key hydrophobic surface residues of 11 beta-hydroxysteroid dehydrogenase type 1 increase solubility and monodispersity in a bacterial expression system.

Authors:  Alexander J Lawson; Elizabeth A Walker; Scott A White; Timothy R Dafforn; Paul M Stewart; Jonathan P Ride
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

Review 2.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

3.  Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice.

Authors:  Samantha L Goggin; Matthew T Labrecque; Andrea M Allan
Journal:  Neurotoxicology       Date:  2012-08-31       Impact factor: 4.294

4.  A novel NADP(+)-dependent dehydrogenase activity for 7alpha/beta- and 11beta-hydroxysteroids in human liver nuclei: A third 11beta-hydroxysteroid dehydrogenase.

Authors:  B Robinzon; R A Prough
Journal:  Arch Biochem Biophys       Date:  2009-05-03       Impact factor: 4.013

5.  Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Nina M Semjonous; Mark Sherlock; Pancharatnam Jeyasuria; Keith L Parker; Elizabeth A Walker; Paul M Stewart; Gareth G Lavery
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

Review 6.  11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

7.  Substrate binding process and mechanistic functioning of type 1 11β-hydroxysteroid dehydrogenase from enhanced sampling methods.

Authors:  Angelo D Favia; Matteo Masetti; Maurizio Recanatini; Andrea Cavalli
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

8.  Mineralocorticoid hypertension.

Authors:  Vishal Gupta
Journal:  Indian J Endocrinol Metab       Date:  2011-10

9.  Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.

Authors:  Alexander J Lawson; Elizabeth A Walker; Gareth G Lavery; Iwona J Bujalska; Beverly Hughes; Wiebke Arlt; Paul M Stewart; Jonathan P Ride
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

10.  A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.

Authors:  I J Bujalska; L L Gathercole; J W Tomlinson; C Darimont; J Ermolieff; A N Fanjul; P A Rejto; P M Stewart
Journal:  J Endocrinol       Date:  2008-05       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.